{"id":"https://openalex.org/W2906820539","doi":"https://doi.org/10.1097/md.0000000000014011","title":"Novel EZH2 mutation in a patient with secondary B-cell acute lymphocytic leukemia after deletion 5q myelodysplastic syndrome treated with lenalidomide","display_name":"Novel EZH2 mutation in a patient with secondary B-cell acute lymphocytic leukemia after deletion 5q myelodysplastic syndrome treated with lenalidomide","publication_year":2019,"publication_date":"2019-01-01","ids":{"openalex":"https://openalex.org/W2906820539","doi":"https://doi.org/10.1097/md.0000000000014011","mag":"2906820539","pmid":"https://pubmed.ncbi.nlm.nih.gov/30608448","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6344201"},"language":"en","primary_location":{"id":"doi:10.1097/md.0000000000014011","doi":"https://doi.org/10.1097/md.0000000000014011","is_oa":true,"landing_page_url":"https://doi.org/10.1097/md.0000000000014011","pdf_url":null,"source":{"id":"https://openalex.org/S28966261","display_name":"Medicine","issn_l":"0025-7974","issn":["0025-7974","1536-5964"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1097/md.0000000000014011","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069567866","display_name":"Sebasti\u00e1n Burgos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8961855","display_name":"Universidad Nacional Aut\u00f3noma de M\u00e9xico","ror":"https://ror.org/01tmp8f25","country_code":"MX","type":"education","lineage":["https://openalex.org/I8961855"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Sebastian Burgos","raw_affiliation_strings":["Universidad Nacional Aut\u00f3noma de M\u00e9xico, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad Nacional Aut\u00f3noma de M\u00e9xico, Mexico City, Mexico","institution_ids":["https://openalex.org/I8961855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028081179","display_name":"Guillermo Montalban Bravo","orcid":"https://orcid.org/0000-0002-4533-5176","observed_orcids":["https://orcid.org/0000-0002-4533-5176"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guillermo Montalban-Bravo","raw_affiliation_strings":["Department of Leukemia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003186923","display_name":"Luc\u00eda Fuente","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125926","display_name":"Instituto Alexander Fleming","ror":"https://ror.org/02b0zvv74","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210125926"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Lucia Fuente","raw_affiliation_strings":["Instituto Alexander Fleming"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Alexander Fleming","institution_ids":["https://openalex.org/I4210125926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049385583","display_name":"Elias Joseph Jabbour","orcid":"https://orcid.org/0000-0003-4465-6119","observed_orcids":["https://orcid.org/0000-0003-4465-6119"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elias J. Jabbour","raw_affiliation_strings":["Department of Leukemia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059373442","display_name":"Rashmi Kanagal\u2010Shamanna","orcid":"https://orcid.org/0000-0001-7829-5249","observed_orcids":["https://orcid.org/0000-0001-7829-5249"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rashmi Kanagal-Shamanna","raw_affiliation_strings":["Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005878960","display_name":"Kelly A. Soltysiak","orcid":"https://orcid.org/0000-0001-6113-3745","observed_orcids":["https://orcid.org/0000-0001-6113-3745"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kelly A. Soltysiak","raw_affiliation_strings":["Department of Leukemia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061026876","display_name":"Guillermo Garcia\u2010Manero","orcid":"https://orcid.org/0000-0002-3631-2482","observed_orcids":["https://orcid.org/0000-0002-3631-2482"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Guillermo Garcia-Manero","raw_affiliation_strings":["Department of Leukemia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079130030","display_name":"Mar\u00eda J. Mela-Osorio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131024","display_name":"Fundaci\u00f3n para la Investigaci\u00f3n, Docencia y Prevenci\u00f3n del C\u00e1ncer","ror":"https://ror.org/02z3t5745","country_code":"AR","type":"nonprofit","lineage":["https://openalex.org/I4210131024"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Maria J. Mela-Osorio","raw_affiliation_strings":["FUNDALEU, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FUNDALEU, Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4210131024"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5061026876"],"corresponding_institution_ids":[],"apc_list":{"value":1950,"currency":"USD","value_usd":1950},"apc_paid":{"value":1950,"currency":"USD","value_usd":1950},"fwci":1.8261,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.84867445,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"98","issue":"1","first_page":"e14011","last_page":"e14011"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9648000001907349,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9648000001907349,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.024700000882148743,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ezh2-mutation","display_name":"EZH2 mutation","score":0.8059999942779541},{"id":"https://openalex.org/keywords/b-cell-acute-lymphoblastic-leukemia","display_name":"B-cell acute lymphoblastic leukemia","score":0.7919999957084656},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome-transformation","display_name":"myelodysplastic syndrome transformation","score":0.9100000262260437},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9620000123977661},{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":0.7900000214576721},{"id":"https://openalex.org/keywords/ring-sideroblasts","display_name":"ring sideroblasts","score":0.6769999861717224},{"id":"https://openalex.org/keywords/multilineage-dysplasia","display_name":"multilineage dysplasia","score":0.6069999933242798}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.902807354927063},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.7693358659744263},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5127228498458862},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.503102719783783},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.451768159866333},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.4451286196708679},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.4303413927555084},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4169784188270569},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.2094445526599884},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000071221","descriptor_name":"Enhancer of Zeste Homolog 2 Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D000077269","descriptor_name":"Lenalidomide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000077269","descriptor_name":"Lenalidomide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D001853","descriptor_name":"Bone Marrow","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002872","descriptor_name":"Chromosome Deletion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D013921","descriptor_name":"Thrombocytopenia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1097/md.0000000000014011","doi":"https://doi.org/10.1097/md.0000000000014011","is_oa":true,"landing_page_url":"https://doi.org/10.1097/md.0000000000014011","pdf_url":null,"source":{"id":"https://openalex.org/S28966261","display_name":"Medicine","issn_l":"0025-7974","issn":["0025-7974","1536-5964"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5339083","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6344201","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6344201","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6344201","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine (Baltimore)","raw_type":"Text"},{"id":"pmid:30608448","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30608448","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.1097/md.0000000000014011","doi":"https://doi.org/10.1097/md.0000000000014011","is_oa":true,"landing_page_url":"https://doi.org/10.1097/md.0000000000014011","pdf_url":null,"source":{"id":"https://openalex.org/S28966261","display_name":"Medicine","issn_l":"0025-7974","issn":["0025-7974","1536-5964"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[{"id":"https://openalex.org/G1398229989","display_name":null,"funder_award_id":"280148","funder_id":"https://openalex.org/F4320321739","funder_display_name":"Consejo Nacional de Ciencia y Tecnolog\u00eda"},{"id":"https://openalex.org/G1468253849","display_name":null,"funder_award_id":"(CA016672)","funder_id":"https://openalex.org/F4320332521","funder_display_name":"University of Texas MD Anderson Cancer Center"},{"id":"https://openalex.org/G3400514463","display_name":null,"funder_award_id":"grant CA016672","funder_id":"https://openalex.org/F4320332521","funder_display_name":"University of Texas MD Anderson Cancer Center"},{"id":"https://openalex.org/G9000878657","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA016672","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320315418","display_name":"Acceleron","ror":"https://ror.org/023annq56"},{"id":"https://openalex.org/F4320321739","display_name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","ror":"https://ror.org/059ex5q34"},{"id":"https://openalex.org/F4320332521","display_name":"University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1528589025","https://openalex.org/W1839228665","https://openalex.org/W1871250652","https://openalex.org/W1902499621","https://openalex.org/W1958987550","https://openalex.org/W1989909968","https://openalex.org/W2004842295","https://openalex.org/W2016644845","https://openalex.org/W2070152906","https://openalex.org/W2114492363","https://openalex.org/W2125378091","https://openalex.org/W2150053844","https://openalex.org/W2167021542","https://openalex.org/W2202440832","https://openalex.org/W2271837396","https://openalex.org/W6639829829"],"related_works":["https://openalex.org/W2752534224","https://openalex.org/W2043129733","https://openalex.org/W2592413587","https://openalex.org/W7213939169","https://openalex.org/W2340404241","https://openalex.org/W7126071440","https://openalex.org/W1902499621","https://openalex.org/W154370382","https://openalex.org/W2131128792","https://openalex.org/W2980256148"],"abstract_inverted_index":{"RATIONALE:":[0],"The":[1,24,234,255],"gene":[2,92],"deletion":[3],"(5)(q22q35)":[4],"is":[5,15,236,246],"reported":[6],"in":[7,90,166],"10-20%":[8],"of":[9,31,44,94,103,123,127,148,160,169,181,232,263,277,287],"myelodysplastic":[10],"syndrome":[11],"(MDS)":[12],"cases":[13],"and":[14,21,66,84,120,177,186,243,245,249,272,292],"associated":[16,42],"with":[17,40,50,58,69,105,116,135,225,268],"response":[18],"to":[19,34,266],"lenalidomide":[20,74],"favorable":[22],"prognosis.":[23],"authors":[25],"report":[26],"here":[27],"a":[28,86,107,121,161,273,290],"clinical":[29,178],"case":[30,283],"MDS":[32,265],"transformation":[33],"B-cell":[35,81],"acute":[36,80],"lymphocytic":[37,82],"leukemia":[38,83],"(B-ALL)":[39],"an":[41,45,259,278],"accrual":[43,159],"additional":[46],"mutation":[47,89,163],"following":[48],"treatment":[49],"lenalidomide.":[51],"PATIENT":[52],"CONCERNS:":[53],"A":[54,171,212],"69-year-old":[55],"man":[56],"presented":[57],"progressive":[59],"anemia,":[60],"normal":[61],"white":[62],"blood":[63],"cell":[64],"count,":[65],"thrombocytopenia":[67],"consistent":[68,134],"MDS.":[70,296],"He":[71],"was":[72,141,206,215],"administered":[73,207],"for":[75,208,295],"27":[76,101],"months,":[77],"then":[78],"developed":[79],"acquired":[85],"previously":[87],"unreported":[88],"the":[91,139,158,285],"enhancer":[93],"zeste":[95],"homolog":[96],"2":[97,217],"(EZH2).":[98],"DIAGNOSES:":[99],"After":[100],"months":[102,218],"therapy":[104],"lenalidomide,":[106],"surveillance":[108,293],"bone":[109,129,152],"marrow":[110,130,153],"aspiration":[111],"(BMA)":[112],"revealed":[113],"90%":[114],"cellularity":[115],"persistent":[117],"multilineage":[118],"dysplasia":[119],"population":[122],"blasts":[124,176],"comprising":[125],"54%":[126],"all":[128],"elements":[131],"by":[132],"morphology,":[133],"B-ALL,":[136],"even":[137],"though":[138],"patient":[140,235],"asymptomatic.":[142],"Conventional":[143],"karyotype":[144],"showed":[145],"no":[146,192,230],"signs":[147],"del(5)(q22q35)":[149,264],"MDS,":[150],"however":[151],"next-generation":[154],"sequencing":[155],"(NGS)":[156],"demonstrated":[157],"nonsense":[162],"(c.211del":[164],"pL71*)":[165],"exon":[167],"3":[168],"EZH2.":[170],"confirmatory":[172],"BMA":[173,214],"yielded":[174],"70%":[175],"features":[179,224],"indicative":[180],"B-ALL.":[182,233],"INTERVENTIONS:":[183],"Mini-hyper-CVD":[184],"(cyclophosphamide":[185],"dexamethasone":[187],"at":[188,195,200],"50%":[189],"dose":[190,197,240],"reduction,":[191,198],"anthracycline,":[193],"methotrexate":[194],"75%":[196],"cytarabine":[199],"0.5":[201],"g/m":[202],"\u00d7":[203],"4":[204],"doses)":[205],"21":[209],"days.":[210],"OUTCOMES:":[211],"follow-up":[213],"performed":[216],"after":[219,251],"mini-hyper-CVD":[220],"therapy,":[221],"showing":[222],"dysplastic":[223],"25%":[226],"ring":[227],"sideroblasts,":[228],"but":[229],"evidence":[231],"currently":[237],"receiving":[238],"monthly-low":[239],"decitabine,":[241],"ofatumumab,":[242],"dexamethasone,":[244],"transfusion":[247],"independent":[248],"asymptomatic":[250],"7":[252],"cycles.":[253],"LESSONS:":[254],"present":[256],"study":[257],"shows":[258],"extremely":[260],"rare":[261],"progression":[262],"B-ALL":[267],"accompanying":[269],"NGS":[270,288],"data":[271],"newly":[274],"described":[275],"acquisition":[276],"EZH2":[279],"frameshift":[280],"mutation.":[281],"This":[282],"highlights":[284],"importance":[286],"as":[289],"diagnostic":[291],"tool":[294]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-01-11T00:00:00"}